Orion Capital Management LLC Ionis Pharmaceuticals Inc Transaction History

Orion Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$42.03 - $53.55 $1,765 - $2,249	42 Added 110.53%	80 $3,000
Q3 2023 Nov 15, 2023	BUY	$38.5 - $47.13 $1,463 - $1,790	38 New	38 $1,000
Q1 2022 May 11, 2022	SELL	$29.88 - $37.04 $14,940 - $18,520	-500 Reduced 92.94%	38 $1,000
Q4 2021 Feb 07, 2022	BUY	$25.61 - $35.1 $12,805 - $17,550	500 Added 1315.79%	538 $16,000
Q4 2020 Feb 23, 2021	BUY	$45.3 - $60.27 $1,721 - $2,290	38 New	38 $2,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Orion Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Orion Capital Management LLC with notifications on news.